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Vitamin D signaling modulates a variety of immune responses. Here, we assessed the role of vitamin D in immunity to
experimental leishmaniasis infection in vitamin D receptor-deﬁcient mice (VDRKO). We observed that VDRKO mice on a
genetically resistant background have decreased Leishmania major-induced lesion development compared to wild-type (WT)
mice; additionally, parasite loads in infected dermis were signiﬁcantly lower at the height of infection. Enzymatic depletion of
the active form of vitamin D mimics the ablation of VDR resulting in an increased resistance to L. major.C o n v e r s e l y ,V D R K O
or vitamin D-deﬁcient mice on the susceptible Th2-biased background had no change in susceptibility. These studies indicate
vitamin D deﬁciency, either through the ablation of VDR or elimination of its ligand, 1,25D3, leads to an increase resistance to L.
major infection but only in a host that is predisposed for Th-1 immune responses.
1.Introduction
The initial metabolism of vitamin D3 occurs in the skin
where 7-dehydrocholesterol is converted to previtamin D3
after exposure to UVB radiation. After isomerization, vita-
min D3 is metabolized by hepatic 25-hydroxylase (CYP2R1)
to form 25-hydroxyvitamin D3 (25OHD3), which is the
major circulating form of vitamin D3. 25OHD3 is metab-
olized by 1α-hydroxylase (CYP27B1) that is present in the
kidney and many other target tissues including the skin.
The active form of vitamin D3,1 α,25 dihydroxyvitamin D3
(1,25D3) translocates to the nucleus of target cells, where it
binds to the vitamin D receptor (VDR), a member of the
nuclearreceptorsupergenefamily.TheVDRheterodimerizes
with the retinoid X receptor and this complex recognizes
vitaminDresponseelementsinthepromotersofmanygenes
to modulate their transcription.
1,25D3 is well characterized for its function in main-
taining appropriate serum calcium concentrations as well
as its critical requirement for proper bone formation. In
addition to these roles, 1,25D3 is important in the regulation
of immune responses. Vitamin D has important roles in
leukocyte diﬀerentiation, dendritic cell maturation, and
modulation of the T-helper cell dichotomy [1–5]. Symptoms
of Th-1-mediated autoimmune diseases can be reduced or
eliminated by treatment with 1,25D3 [6–8]. In addition to
its role in autoimmune disease, recent studies have explored
a role for vitamin D-mediated signaling in infectious disease
resistance [9]. For example, Mycobacterium tuberculosis
infection induces both VDR and 1-α hydroxylase, which
are necessary for production of cathelicidin as part of an
antimicrobial peptide response against the M. tuberculosis
infection in vitro [10]. Here, we investigated the role
of VDR in immunity to murine experimental cutaneous
leishmaniasis (CL), the prototypical in vivo model of the
Th-1/Th-2 dichotomy. Parasites from the genus Leishmania
are responsible for a spectrum of diseases ranging from self-
healing cutaneous disease to the potentially fatal visceral
disease. Immunity to L. major, a parasite responsible for
cutaneous leishmaniasis, is highly dependent on a strong2 Journal of Parasitology Research
IFNγ-mediated T-helper 1 (Th-1) response. This Th-1
response induces production of nitric oxide (NO) which is
critical in elimination of parasites.
We report that VDRKO mice exhibit decreased lesion
development as well as decreased parasite loads at the height
of L. major infection. Additionally, we demonstrate that
resistant mice that are rendered vitamin D-deﬁcient by
ablation of the 1-α hydroxylase enzyme in CYP27B1 KO
mice mimic VDRKO mice with regards to decreased lesion
development, suggesting that the eﬀect is dependent on the
presence of the ligand. Surprisingly, deﬁciency of vitamin D
signaling in genetically susceptible mice has no eﬀect on L.
major infection.
2.MaterialsandMethods
2.1. Mice. VDRKO [11], CYP27B1KO [12], and WT mice,
on both BALB/c and C57BL/6 backgrounds, were main-
tained at Friemann Life Sciences Center at the University
of Notre Dame (Notre Dame, Ind, USA). To generate the
BALB/c VDRKO strain, female C57BL/6 VDRKO mice were
bred with WT male BALB/c mice. The female oﬀspring
from this mating were genotyped by PCR [11] and the
mice identiﬁed as heterozygous for the VDRKO allele were
backcrossed to WT male BALB/c mice. This process was
repeated 7 times resulting in mice with a greater than
99.2% BALB/c background. Male and female heterozygous
mice were bred to each other to generate oﬀspring that
were homozygous for either the VDRKO allele or for
the WT allele. These homozygous mice were then used
to establish a breeding colony of both VDRKO and WT
mice on a BALB/c background. VDRKO and WT mice
were maintained from weaning on a high-calcium, high-
lactoserescuediet(TD96348;Teklad,Madison,Wis,USA)to
prevent hypocalcemia associated with VDR deﬁciency [13].
All animal protocols were approved and reviewed by the
University of Notre Dame Institutional Animal Care and
Use Committee (IACUC). All mice used in the experiments
describedbelowwerefemalesbetween1and4monthsofage.
WT female mice were age-matched for all experiments.
2.2. Parasites and Infection. L. major NIH Friedlin V1 strain
(MHOM/IL/80/FN) was used in this study. The parasites
were cultivated and infective stage, metacyclic promastigotes
were generated as previously described [14]. For infections,
1×105 metacyclic promastigotes in 20μL of PBS were
injected intradermally into the outside surface of the ear.
Lesion diameter and thickness and ulcer diameter was
measured weekly with a digital vernier caliper. A lesion
“score” was calculated by adding the values obtained for
lesiondiameter,ulcerdiameter,andlesionthickness.Infected
ear tissue was homogenized to determine relative parasite
load by performing a limiting dilution assay as previously
described [15].
2.3. Histology. Segments of ear tissue were embedded in
Tissue-Tek OCT freezing media (Fisher Scientiﬁc, Pitts-
burgh, PA), sectioned and stained with Mayer’s hematoxylin
and eosin to distinguish cytoplasm and nuclei, respectively.
Images were obtained using a Nikon E400 light microscope
(Nikon, Melville, NY, USA).
2.4. IgG Subclass Determination. Collected sera was used
in a soluble Leishmania antigen (SLA) speciﬁc ELISA. IgG
subclass speciﬁc secondary antibodies (Southern Biotech,
Birmingham, Ala, USA) were used to determine IgG subclass
levels. Absorbances were recorded using a SpectraMax M2
platereader(MolecularDevices,Sunnyvale,Calif,USA).Sera
from mice 12 weeks after post-infection were pooled and
run as a normalizing sample on each plate. For each isotype,
the absorbance for each normalizing sample was used to
generate a mean absorbance (ABS). Plate to plate variation
was eliminated by using the equation (mean ABS/plate ABS)
× (plate ABS) = normalized ABS.
2.5. Quantitative RT-PCR Analysis. Total RNA was isolated
from pulverized ears using an RNeasy Mini kit (Qiagen,
Valencia, Calif, USA) according to the manufacturer’s
instructions and contaminating DNA was removed via
DNase I treatment (Invitrogen, Carlsbad, Calif, USA).
Reverse transcription was performed using 1μgo fD N A -
free total RNA, 250ng random primers (Invitrogen), and
SuperScript III kit (Invitrogen). Real-time PCR was per-
formed on an ABI 7900HT sequence detection analyzer
(Applied Biosystems, Foster City, Calif, USA) using the 2x
SYBRGreenKit(AppliedBiosystems).Theprimers(300nM;
IDT, Coralville, Iolua, USA) used were HPRT, IFNγ,I L -
4, IL-12p40 [16], Arg1 [17], iNOS [18], IL-10: 5 -CAC
AAA GCA GCC TTG CAG AA-3 /5  -CTG GCC CCT GCT
GAT CCT-3 ,T N F α:5  -GAA ACA CAA GAT GCT GGG
ACA GT-3 /5  -CAT TCG AGG CTC CAG TGA ATT C-
3 . For FoxP3, gene expression was determined using a pre-
made gene expression assay (Applied Biosystems) according
to manufacturer’s instructions. Relative copy number was
determined using the comparative CT method [19].
2.6. Restimulation Assay. Lymph nodes from infected mice
were disrupted using a syringe plunger and a cell strainer
(BD Biosciences, San Jose, Calif, USA) and cells from 4
mice per condition were pooled and stimulated with 50μgo f
SLA.Cellsupernatantwasharvestedat120hraftertreatment
and was analyzed on a Luminex 200 instrument using
a multiplex biomarker immunoassay (Millipore, Billerica,
Mass, USA). Two biological replicates were assessed, the ﬁrst
in quadruplicate on two separate Luminex plates and the
second in duplicate on one plate.
2.7. Flow Cytometry. FcReceptors were blocked with 10%
normal mouse serum and stained using 1% BSA in PBS.
Cell surface labeling was performed using the following anti-
mouse antibodies: α-CD45, α-CD11b, α-CD11c, α-LY-6C/G,
α-CD4, α-CD8, α-TCR (BD Biosciences), α-F4/80 (Invit-
rogen), and α-FoxP3 (eBioscience, San Diego, Calif, USA).
Appropriate isotype controls were used as negative controls.
Flow cytometry was performed using an FC-500 ﬂowJournal of Parasitology Research 3
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Figure 1: VDRKO mice develop smaller lesions when infected with L. major. C57BL/6 WT (closed circles) and VDRKO (open circles) mice
were infected in the ear with 105 L. major parasites. (a) Cumulative measurement of lesion size (score) was measured over the course of
infection. One representative of 5 independent experiments is presented;
∗P ≤ 0.05. (b) Mice were reinfected upon complete resolution of
theprimaryinfection (wk18)andlesionsweremeasureduntilcompletely healed.Meanlesionscore ±SEispresented;n =(11–21ears).One
representative of 2 independent experiments is presented. (c) Parasite burden of infected ears from VDRKO and WT mice was determined
at 4, 8, and 12 weeks after infection by performing a limiting dilution assay. Each point indicates the parasite load in a single ear. One
representative of 2 independent experiments is presented.
∗P ≤ 0.05.
cytometer (Beckman Coulter, Fullerton, CA) and analyzed
with MXP analysis software (Beckman Coulter).
2.8. Diet Studies. For vitamin D deﬁciency experiments,
mice were fed TD.04179, a vitamin D-deﬁcient diet (Harlan
Teklad) from birth prior to mating with male mice from
the same background. Once weaned, the oﬀspring from
these mice were fed solely using the vitamin D-deﬁcient diet
throughout the study. Mice were infected in the ears and
lesions were measured as previously described. Vitamin D
analysis of serum was performed using both a 25(OH)D3
ELISA and a 1,25D3 ELISA (IDS, Fountain Hills, AZ, USA)
following the manufacturer’s instructions.
2.9. Generation of Bone Marrow Derived Macrophages and
Bone Marrow-Derived Dendritic Cells (DC). Bone marrow
w a sﬂ u s h e df r o mf e m u r sw i t hR P M I - C .R e db l o o dc e l l sw e r e
lysed using ice-cold sterile ACK lysis buﬀer (0.15 M Nh4Cl,
10mM KHCO3,0 . 1 m MN a 2EDTA). Macrophages were
generated as previously described [14]. For the generation
of DC, progenitor cells were counted and resuspended at
2×105/mL in RPMI-C containing 20ng/mL granulocyte
macrophage colony-stimulating factor (GM-CSF) (Pepro-
tech,RockyHill,NJ,USA).Thecellsweresupplementedwith
fresh RPMI-C containing 20ng/mL GM-CSF on days 3, 6, 8,
and 10. On day 12, the cells were transferred to 24 well plates
for the duration of the experiment.4 Journal of Parasitology Research
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Figure 2: Lesion size is reduced in CYP27B1KO mice. C57BL/6 WT (closed circles) and CYP27B1KO (open circles) mice were infected with
105 L. major parasites and the resulting lesions were measured at the indicated time points. Mean ± SE is presented; n = (8–17). (b) Infected
ears were harvested at 4, 8, and 12 weeks after infection, and parasite load was determined by limiting dilution assay. Each point indicates
parasite burden in one ear. One representative of two independent experiments is presented.
∗P ≤ 0.05.
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Figure 3: Deﬁciency of vitamin D signaling does not modulate
resistance in a susceptible mouse strain. VDRKO mice on a
susceptible BALB/c background (open circles) or WT BALB/c
(closed circles) were infected with 105 L. major parasites and the
resulting lesions were measured at the indicated time points. Mean
± SE is presented; n = 14. One representative of two independent
experiments is presented.
2.10. Phagocytosis Assays. Macrophages or DC were treated
with IFN-γ (500U/mL) and/or 1,25D3 (Biomol, Plymouth
M e e t i n g ,P a ,U S A )( 4 0 n M )f o r2 4 h ro rl e f tu n t r e a t e d .
Cells were infected at a ratio of 5:1 with V1 strain L.
major metacyclic promastigotes. Parasites were opsonized
with 5% normal mouse serum for 30 minutes, washed, then
coincubated with the macrophages or dendritic cells for 1, 2,
4, and 24hr. Coverslips were stained with Diﬀ-Quick (Fisher
Scientiﬁc).
WT
Uninfected
VDRKO
Week 4 Week 8 Week 12
Figure 4: Inﬂammation is decreased in the infected ears of
VDRKO mice. C57BL/6 WT and VDRKO were infected in the
ear with 105 L. major parasites. Histological cross sections were
H&E stained at the indicated time points and inﬂammation of the
dermis was assessed visually by microscopy. One representative of 2
independent experiments is presented.
2.11. IL-12 ELISA/Nitric Oxide (NO) Assays. Levels of IL-12
were analyzed using anti-IL-12p40 ELISA (Pierce, Rockford,
Ill, USA). NO production was assessed by Griess reaction
according to the manufacturer’s instructions (Promega,
Madison, Wis, USA).
2.12.StatisticalAnalyses. Forstatisticalanalysisoflesionsize,
analysis of variance (ANOVA) between WT and KO strains
was utilized with a subsequent Bonferonni’s post-test to
determine at what time points the strains were diﬀerent.
Paired t-tests were performed to determine diﬀerences be-
tween WT and KO populations for parasite burdens, IgG
levels, cytokine regulation, and all in vitro analyses. All sta-
tistical analyses were performed using GraphPad Prism 4.0
software. In all cases, a P value ≤ 0.05 was considered sta-
tistically signiﬁcant.Journal of Parasitology Research 5
3. Results
3.1.VDRKOMiceonaC57BL/6BackgroundExhibitIncreased
Resistance to L. major Infection. To investigate the role of
VDR in immunity to L. major infection, C57BL/6 VDRKO
and WT mice were infected in the ear dermis with 105 L.
major metacyclic promastigotes. Both groups of mice devel-
oped lesions that eventually healed; however, VDRKO mice
developedlesionsthatweresigniﬁcantlysmallerandhealed3
weeks faster than their WT counterparts (Figure 1(a)). Upon
reinfection, VDRKO mice did not develop lesions at the
site of secondary infection whereas the WT mice developed
small lesions that resolved within 3 weeks (Figure 1(b)).
These results indicate that VDRKO mice have an increased
resistance to L. major infection compared to WT mice as
demonstrated by decreased lesion development. Addition-
ally, VDRKO mice have an intact and possibly heightened
memory response to secondary infection.
Because VDRKO mice had decreased lesion develop-
ment, we compared the parasite load at the site of infection
between VDRKO and WT mice using a limiting dilution
assay. At 4 weeks after infection, both groups of mice had
similar levels of parasites at the site of infection and at
week 8, the VDRKO mice had signiﬁcantly fewer parasites
compared to the WT mice (Figure 1(c)). However, by 12
weeks after infection, VDRKO mice harbored signiﬁcantly
elevated parasite loads, suggesting that wound healing and
parasite killing may be occurring via diﬀerent mechanisms
[20].
3.2. 1-α Hydroxylase-Deﬁcient Mice Exhibit Heightened Resis-
tance to L. major Infection. CYP27B1KO mice, which lack
the 1-α hydroxylase enzyme required to produce 1,25D3,
displayed prototypical lesion development that is observed
inresistant(C57BL/6) strains ofmice;thatis, lesions develop
after a few weeks and eventually resolve. Similar to VDRKO
mice, CYP27B1KO mice developed signiﬁcantly smaller
lesions compared to their WT counterparts throughout
the ﬁrst 6 weeks of infection (Figure 2(a)). CYP27B1KO
mice resolved their infections at a similar rate as WT mice
a n db o t hg r o u p sw e r ec o m p l e t e l yh e a l e db yw e e k1 1a f t e r
infection. Parasite quantiﬁcation of infected ears from these
groups of mice demonstrated that that CYP27B1KO and
WT mice possess similar parasite burdens throughout the
infection (Figure 2(b)).
3.3. VDR Ablation Does Not Aﬀect L. major Infection in
BALB/c Mice. C57BL/6 mice have the propensity to com-
pletely heal after Leishmania infection, whereas BALB/c mice
are unable to heal or resolve L. major induced lesions.
Unlike C57BL/6 VDRKO mice, VDRKO mice on a suscep-
tible BALB/c background did not develop smaller lesions
compared to their WT counterparts (Figure 3).
3.4. VDRKO Mice Exhibit Decreased Inﬂammation at the Site
of Infection. To investigate the causes of reduced lesions and
parasite burden in C57BL/6 VDRKO mice, we performed
furtheranalysesonlesionsandimmuneresponsestoL.major
infection. VDRKO mice exhibit alopecia, develop dermal
cysts, and do not recycle epidermal layers properly [21, 22].
To assess if these skin diﬀerences were involved in the
diﬀerential lesion development, we performed a histological
study to explore lesion architecture. Uninfected C57BL/6
VDRKO and WT mice do not have any diﬀerences in their
skin architecture and displayed no characteristics indicative
of inﬂammation (Figure 4). At 4 weeks after infection, both
VDRKO and WT mice exhibit similar levels of inﬂammation
at the site of infection. Although numbers of inﬁltrating
cells were similar in the two mouse strains through 8 weeks
of infection (data not shown), VDRKO mice appeared to
display decreased inﬂammation by 8 weeks after infection
(Figure 4). Inﬂammation continued to decrease in both
groups of mice, and by 12 weeks after infection lesions
from VDRKO mice exhibited little signs of inﬂammation.
Inﬂammation was still observed in the WT mice at 12 weeks
after infection although greatly reduced.
There were no signiﬁcant diﬀerences between WT and
VDRKO mice in terms of macrophage (CD11b+/F480+),
neutrophil (Ly-6C/G+/F480-), T cell (CD4+ or CD8+), or
dendritic cell (CD11c+) cell inﬁltration (data not shown).
WT mice produced more IFNγ and IL-10 mRNA at the
infection site 2 weeks after L. major infection (Figure 5). In
addition, IL-4 and IL-12 mRNA was elevated in WT mice
compared to VDRKO mice. Inducible nitric oxide synthase
(iNOS) was upregulated during L. major infection, however
no diﬀerences between WT and VDRKO were detected. As
previously reported [17], WT mice express more arginase
mRNA than VDRKO mice (Figure 5).
3.5. Systemic Immune Responses in VDR KO and WT
Mice. Flow cytometry analysis of the draining lymph
nodes indicated that T-helper cells (CD4+), cytotoxic T-
cells (CD8+), and FoxP3+ Treg (CD4+/CD25+) cells are
elevated in VDRKO mice at most time points relative to
WT animals (Suppl. Figure 1 which is available online at
doi:10.1155/2012/134645). The number of each of these
cell types increased as the lesions progressed and then
decreased during healing. No obvious diﬀerences in other
cell types such as macrophages (CD11b+/F480+), dendritic
cells (CD11c+), or neutrophils (LY-6C/G+/F480-) were
observed in the draining lymph nodes (data not shown).
VDRKO lymph node cells produced signiﬁcantly lower
amounts of inﬂammatory cytokines IFNγ,T N F - α,G M - C S F ,
and MIP-1α at the height of infection than the cells from
WT mice (Suppl. Figure 2). Conversely, more MCP-1 was
produced by lymph node cells from VDRKO mice compared
to the cells from WT mice. Early after infection (2 weeks),
cells from both mouse strains up regulated IL-4, IL-5, and
IL-13, production that decreased by 12 wks post-infection
(Suppl. Figure 2). Furthermore, VDRKO and WT lymph
nodes generated equivalent amounts of IL-1β, IL-6, IL-10,
Rantes, and KC at all time points.
TotalIgGserumlevelsincreasedinbothgroupsofmiceas
lesion development progressed and remained elevated even
after the mice had healed (Figure 6). Signiﬁcantly elevated
levels of IgG2a/c were detected in VDRKO mice beginning
at week 4 after infection and remained signiﬁcantly elevated6 Journal of Parasitology Research
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Figure 5: Quantitative RT-PCR analysis of cytokine production at the site of infection. C57BL/6 WT (closed circles) and VDRKO (open
circles) mice were infected with 105 L. major parasites and their ears were harvested at the indicated time points. Quantitative RT-PCR was
performed to determine the fold increase over uninfected WT ears for each cytokine. One representative of two independent experiments is
presented.
∗P ≤ 0.05. n = 4 mice/time point.
throughoutinfection(Figure 6).NodiﬀerencesinIgG1titers
wereobservedbetweentheVDRKOandWTmiceatanytime
point (data not shown).
3.6. NO and IL-12 Production Are Increased in DC from
VDRKO C57BL/6 Mice. NO production is a potent mech-
anism used by antigen presenting cells to eliminate L.
major parasites. DC from both groups of mice were either
left untreated or preincubated with combinations of IFN-γ
and/or 1,25D3 prior to L. major infection and 48 hours after
infection, cell culture supernatant was analyzed for levels
of NO production. DC from VDRKO generate signiﬁcantly
more NO upon stimulation with IFNγ or IFNγ and 1,25D3
(Figure 7(a)). Preincubation of IFNγ or a combinationJournal of Parasitology Research 7
of IFNγ and 1,25D3 resulted in signiﬁcantly more NO
production as compared to untreated cells in both cell types.
We did not observe an inhibition of NO production by the
DCupontreatmentwith1,25D3ineithertheVDRKOorWT
derived cells. In addition, there is no eﬀect of either the VDR
o r1 , 2 5 D 3o nN Op r o d u c t i o ni nm a c r o p h a g e s( S u p p l .F i g u r e
3(a)).
Regardless of the IFNγ and/or 1,25D3 treatment, IL-
12p40 production by VDRKO DC is signiﬁcantly increased
compared to WT DC, suggesting that VDR may contribute
to regulation of IL-12p40 production by DC (Figure 7(b)).
4. Discussion
Leishmania are obligate intracellular parasites that are elim-
inated by a strong Th-1 host response. Vitamin D treatment
reduces inappropriate Th-1 responses thus decreasing or
eliminating symptoms of autoimmune diseases [6–8, 23].
As vitamin D exerts these eﬀects through the VDR, we
hypothesized that ablation of the VDR would tilt the Th-
1/Th-2 balance towards a Th-1 bias and lead to enhanced
resistance to L. major infection. Using a mouse model
of cutaneous leishmaniasis, in which the parasites were
injected into the ear dermis, we observed that VDRKO
mice developed signiﬁcantly smaller lesions and have fewer
parasites at the site ofinfection during the height of infection
than their WT counterparts. These results are similar to
those observed by previous studies using a foot pad model of
cutaneousleishmaniasis [17].AsVDRKOmice healedearlier
than WT mice, we anticipated that VDRKO mice would
exhibit decreased parasite loads compared to WT mice,
becauseVDRKOmiceresolvetheirlesionsmorequicklythan
WT mice. However, at 12 weeks after infection, VDRKO
mice had elevated levels of parasites at the infection site even
though they have decreased lesion size. This disparity may
indicate that diﬀerent processes are contributing to wound
healing and parasite killing. The ability of VDRKO mice
to produce increased dermal depositions of collagen may
contribute to the increased healing phenotype we observed
in VDRKO mice, as research indicates that orderly collagen
ﬁber deposition in the skin is one factor that may contribute
to increased healing in L. major infected mice [20].
Successful clearance of a L. major infection depends on
initiation of a robust Th-1 response that leads to parasite
killing via production of NO. VDRKO mice produce signif-
icantly lower levels of inﬂammatory cytokines locally at the
infection site and following restimulation in vitro suggesting
that VDRKO mice generate a decreased Th-1 response
to L. major infection. We expected to detect upregulated
transcription of iNOS in VDRKO mice as this enzyme leads
to production of the NO necessary for killing of L. major;
however, iNOS is not upregulated at any point post L. major
infection in VDRKO compared to WT mice. Rather, arginase
transcript levels are higher in WT compared to VDRKO
mice, supporting the suggestion by others that upregulation
of arginase antagonizes the metabolism of NO by competing
withiNOSforacommonsubstrate,L-arginine[17].Thelack
of such competition would allow VDRKO mice to generate
more NO than WT mice, leading to increased parasite
killing. This hypothesis is further supported by studies
demonstrating that inhibition of arginase by N-hydroxy-L-
arginine, a precursor of NO, results in increased macrophage
killing of L. major parasites in vitro, while induction of
arginase contributes to the growth of L. major by providing
the parasites with the polyamines required for replication
[24, 25].
Toll like receptor activation initiates upregulation of
VDR and CYP27B1 leading to an antimicrobial peptide
response against Mycobacteria [10, 26], which contributes
to killing of M. tuberculosis in human macrophages [27].
This pathway is unlikely to play a role in resistance to L.
major as antimicrobial peptides have little eﬀect in killing of
Leishmania [28, 29]. VDR expression, treatment with IFNγ
and/or vitamin D does not aﬀect the ability of macrophage
and DC to phagocytose L. major (data not shown and
[17]). Furthermore, 1,25D3 treatment alone had no eﬀect
on IFNγ-induced NO production in infected macrophage
and DC in vitro. This contrasts with other published
data suggesting that NO production by L. major infected
macrophages is inhibited by 1,25D3 [17]. These authors
suggest that enhanced production of arginase competes
with iNOS for a common substrate, ultimately resulting in
decreased production of NO in macrophage. Stimulation
of VDRKO macrophage with IFNγ and LPS resulted in
signiﬁcantly less NO than similarly treated WT macrophage
(data not shown) suggesting that VDR may play a role in
modulation of NO production in macrophage. Conversely,
IFNγ-induced NO production by infected VDRKO DC was
signiﬁcantlyhigherthanWTDCimplyingthatVDRablation
increases rather than decreases NO production in DC. Our
data suggests that vitamin D and the VDR diﬀerentially
r e g u l a t eN Op r o d u c t i o ni nm a c r o p h a g ev e r s u sD C .
In addition to overproducing NO, VDRKO DC over-
produce IL-12p40 compared to WT. Other studies demon-
strate that 1,25D3 inhibits IFNγ signaling in both T cells,
macrophages and DC [17, 30–33]. Indirect inhibition of DC
produced NO then could result via VDR inhibition of IFNγ
activated STAT1 signaling. The ablation of the VDR results
in elimination of this inhibition resulting in upregulation
of NO and IL-12p40 production. As a similar increase of
I L - 1 2 p 4 0a n dN Op r o d u c t i o nw a sn o to b s e r v e di nV D R K O
macrophage this implies that macrophage diﬀer from DC in
their IFNγ induced production of IL-12p40.
VDRKOmicegeneratesigniﬁcantlymoreantigenspeciﬁc
IgG2a/c antibodies, that serve as an indicator of Th-1 biased
immune responses [34, 35] than WT mice. The elevated
IgG2a/c production in VDRKO mice is not surprising as
treatment with 1,25D3 inhibits IgG2a production in mice
[36], in cattle [37], and in pigs [38]. These data suggest that
elimination of inhibitory eﬀects of 1,25D3 skews antibody
response towards production of IgG2a/c. The higher levels
of IgG2a/c possibly explain the increased resistance to
secondary infection with L. major observed in the VDRKO
mice (Figure 1(b)). Indeed, elevated antigen speciﬁc and
nonspeciﬁc induction of IgG2a/c has been observed in older
VDRKO mice infected with Listeria monocytogenes [39].
However, the exact relationship between IgG2a/c production
and vitamin D signaling remains to be elucidated.8 Journal of Parasitology Research
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Figure 6: VDRKO mice exhibit elevated IgG2a/c production in response to L. major infection. C57BL/6 WT (closed bars) and VDRKO
(open bars) mice were infected with 105 L. major parasites and serum samples were collected at the indicated time points. Isotype speciﬁc
ELISA was performed to determine levels of total IgG and IgG2a/c in the serum. Mean ± SE is presented; n = (8–10).
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Figure 7: NO and IL-12p40 production by host cells. C57BL/6 WT (closed bars) and VDRKO (open bars) mice. DC were treated with
IFNγ and/or 1,25D3 for 24hr prior to being infected at a ratio of 5:1 with L. major. The cells were infected for 4hr and washed to remove
extracellular parasites. Supernatants were harvested 48hr after infection and analyzed for production of NO (a) and IL-12p40 (b). Mean ±
standard error is presented; (n = 4).
∗P ≤ 0.05.
We demonstrate that neither genetic removal of the
VDR or depletion of vitamin D from the diet (data not
shown) of mice on the BALB/c background does not alter
susceptibility to L. major infection. Susceptibility in WT
BALB/c mice is attributed to their inability to mount a Th-
1 response against infection. Our results indicate that the
eﬀect of the VDR may depend on the nature of the host
immune response. Additional mechanisms, such as wound
healing and genetic background, have also been shown to be
important in resistance to L. major infection [20, 40]. Our
data clearly show that the absence of vitamin D signaling
cannot overcome the susceptibility traits of BALB/c mice.
Contrary to the results observed in VDRKO or
CYP27B1KO mice, dietary deﬁciency of vitamin D in
resistant C57BL/6 mice did not reduce the severity of L.
major lesions (data not shown). A similar disparity has been
observed in studies investigating the role of VDR deletion
versus dietary vitamin D deﬁciency in the development of
diabetes [23, 41]a n dM S[ 8, 42]. Our data may indicate
that some of the eﬀects of VDR on the course of L. majorJournal of Parasitology Research 9
infection are ligand independent, as has been shown in the
case of alopecia [43], or that suﬃcient 1,25D3 persists in
micemaintainedonthedeﬁcientdiettoactivatethereceptor.
In summary, we have demonstrated that VDRKO mice
on the C57BL/6 background develop smaller lesions than
WT mice upon infection with L. major, but this phenotype is
not observed on the BALB/c genetic background. Enzymatic
depletion of 1,25D3 also enhances resistance to L. major
infection in C57BL/6 mice. The data further suggest that
increased IL-12p40 and NO production by VDRKO den-
dritic cellsmay contribute to increased resistance toL. major.
Thesestudies indicate thatablationofVDRorelimination of
its ligand, 1,25D3, is able to increase resistance to L. major
infection, but only in a host that is predisposed for Th-1
immune responses. Our data conﬁrm an important role for
vitamin D for regulating immune responses that depend on
Th-1 cells.
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